FDA grants Mylan generic approval of Astra high blood pressure pill

TriMed Staff | | Health Imaging | Diagnostic Imaging
Mylan Pharmaceuticals has received approval from the FDA for its abbreviated new drug application for felodipine, the generic high blood pressure extended-release tablets USP, 2.5 mg, 5 mg and 10 mg.

Felodipine extended-release tablets USP are the generic version of AstraZeneca Pharmaceutical’s Plendil extended-release tablets, which had U.S. sales of approximately $251 million for the 12 months ending Dec. 31, 2007, according to IMS Health.

The Pittsburgh-based Mylan said it will start shipping felodipine immediately.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.